Stimulation Evaluation for Neuromodulation Sensory Effects

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorAdraxe Corp.

About this trial

The goal of this clinical trial is to learn how healthy adults experience low-level electrical stimulation delivered through the study device. This study is not intended to treat a medical condition.

The main questions it aims to answer are:

Is the study stimulation comfortable and well tolerated? What sensations do participants notice during stimulation? Can participants tell the difference between active stimulation and sham stimulation?

Researchers will compare active stimulation with sham stimulation. Sham stimulation uses the same study procedures but does not deliver the study stimulation. This comparison will help researchers understand whether sensations are caused by stimulation rather than the study setting or expectations.

Participants will:

Receive brief sessions of active and sham stimulation using the study device. Report sensations, discomfort, or other effects during and after each session. Complete questionnaires or other assessments about their experience with stimulation.

The information from this study will help researchers select stimulation settings and procedures for future studies.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age ≥18 years.

Self-reported good general health, as assessed by study personnel.

Disqualifiers

Non-English speaking

History of epilepsy, seizure disorder, unprovoked seizure, or status epilepticus.

History of febrile seizures beyond early childhood

Current use of medications known to substantially lower seizure threshold, including but not limited to certain antidepressants, antipsychotics, stimulants,

Trial design

Design model

Single group

Treatments tested in this trial

  • Intersectional Short-Pulse (ISP) Stimulation

    Device

    Active Intersectional Short-Pulse (ISP) stimulation is low-level electrical stimulation delivered through the study device during brief study sessions. The study team will apply stimulation using pre-specified settings and monitor participant comfort. Participants will report any sensations or discomfort during and after stimulation.

  • Sham Stimulation

    Device

    Sham stimulation uses the same study device, electrode placement, and study procedures as active ISP stimulation, but does not deliver the study stimulation. It is included to help compare participant-reported sensations during active and sham sessions.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Healthy VolunteerExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Number of Participants Who Complete Active and Sham Stimulation Sessions Without Intolerable Discomfort or Session Discontinuation

Participant ability to distinguish active stimulation from sham stimulation will be assessed by the participant's post-session identification of the stimulation condition. The proportion of correct condition identifications will be summarized and evaluated relative to chance performance.

Time frame
From enrollment to the end of the, approximately 2 hour, stimulation session.
2

Healthy adult volunteers- receive low amplitude sham and active ISP stimulation

Time frame
From enrollment to the end of the single day assessment

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: